
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.58 | 2.58 | 0.00 |
Shares | 97.42 | 97.42 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.91 | 19.72 |
Price to Book | 3.57 | 3.90 |
Price to Sales | 1.98 | 2.23 |
Price to Cash Flow | 13.88 | 15.00 |
Dividend Yield | 1.59 | 1.50 |
5 Years Earnings Growth | 8.12 | 9.86 |
Number of long holdings: 91
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.45 | 635.33 | +1.55% | |
Roche Holding Participation | CH0012032048 | 4.20 | 246.30 | -0.04% | |
Novo Nordisk B | DK0062498333 | 3.89 | 322.6 | -0.12% | |
AstraZeneca | GB0009895292 | 3.79 | 11,036.0 | +1.04% | |
Intuitive Surgical | US46120E6023 | 3.50 | 471.70 | +0.34% | |
AbbVie | US00287Y1091 | 3.19 | 198.67 | +0.31% | |
Boston Scientific | US1011371077 | 3.16 | 102.75 | -0.38% | |
Medtronic | IE00BTN1Y115 | 3.15 | 92.74 | -0.15% | |
Stryker | US8636671013 | 3.14 | 376.67 | -0.24% | |
Thermo Fisher Scientific | US8835561023 | 2.90 | 462.39 | +0.36% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
QEP Global Core Equity Fund A Acc | 1.9B | 7.07 | 14.13 | 13.04 | ||
QEP Global Core Equity Fund A Inc | 1.9B | 7.05 | 14.14 | 13.03 | ||
QEP Global Core Equity Fund X Acc | 1.9B | 7.22 | 14.47 | 13.38 | ||
Schroder Global Equity Fund I Acc | 2.21B | -0.17 | 14.45 | 13.16 | ||
Schroder Global Equity Fund I Inc | 2.21B | -0.19 | 14.42 | 13.16 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review